Researchers say ‘relatively simple, inexpensive’ means of assessing genetic risk offers hope of better screening
An at-home spit test appears to perform better at predicting prostate cancer risk than the current frontline test, a study suggests.
The test assesses 130 genetic variants to provide a risk score for prostate cancer, which is the second most common cause of cancer deaths in men in the UK.
More Stories
Revealed: Chinese researchers can access half a million UK GP records
About 15% of world’s cropland polluted with toxic metals, say researchers
Rebecca Hendin on life outside our solar system – cartoon